Hydralazine-valproate: a repositioned drug combination for the epigenetic therapy of cancer.

Hydralazine-valproate: a repositioned drug combination for the epigenetic therapy of cancer.

Item
http://www.wikidata.org/entity/Q38242979
Association of Smoking, Alcohol Use, and Betel Quid Chewing with Epigenetic Aberrations in Cancers.DNA Methylation Targeting: The DNMT/HMT Crosstalk Challenge.Epigenetics: new possibilities for drug discovery.Effects of In Utero Exposure to Ethinyl Estradiol on Tamoxifen Resistance and Breast Cancer Recurrence in a Preclinical Model.DNA Methyltransferase Inhibitors: Development and Applications.N-Acetyltransferase 2 Genotype-Dependent N-Acetylation of Hydralazine in Human Hepatocytes.Encouraging results with the compassionate use of hydralazine/valproate (TRANSKRIP™) as epigenetic treatment for myelodysplastic syndrome (MDS).What is the potential of epigenetics in drug development?Epigenetic actions of environmental factors and promising drugs for cancer therapy.Efficacy of hydralazine and valproate in cutaneous T-cell lymphoma, a phase II study.Epigenetics and Metabolism in Health and Disease
P2860

Hydralazine-valproate: a repositioned drug combination for the epigenetic therapy of cancer.

Item
http://www.wikidata.org/entity/Q38242979
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Hydralazine-valproate: a repos ...... epigenetic therapy of cancer.
@en
type
label
Hydralazine-valproate: a repos ...... epigenetic therapy of cancer.
@en
prefLabel
Hydralazine-valproate: a repos ...... epigenetic therapy of cancer.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P356
P1433
P1476
Hydralazine-valproate: a repos ...... epigenetic therapy of cancer.
@en
P2093
P2860
P304
P31
P356
10.1517/17425255.2014.947263
P407
P433
P478
P577
P5875
P698